WEIFANG HOTA NEW MATERIAL TECHNOLOGY CO., LTD.

Introduction

WEIFANG HOTA NEW MATERIAL TECHNOLOGY CO., LTD. is a Chinese manufacturer and trading enterprise based in Weifang, Shandong, that operates across medical consumables, non-woven protective products, and selected new-material and chemical product lines. The company presents itself as a wholly owned subsidiary of Hota Group and as a supplier of surgical packs, surgical drapes, equipment covers, wound-care products, laboratory and dental supplies, and related hospital and home-care items.

In industry terms, Hota is positioned at the intersection of medical nonwovens, single-use healthcare supplies, and broader plastics and chemical distribution, with an export-oriented business model and multi-country sourcing and supply-chain links. Its corporate materials also emphasize OEM/ODM services, technical support, quality management, and participation in international trade channels, including the Chinaplas exhibitor platform.

History and Development

Hota’s public-facing materials contain more than one establishment date, which suggests that the brand, operating entity, and group structure have evolved over time rather than being described consistently across platforms. Some sources describe the company as founded in 2015 or 2016, while others state that registration records show a 2020 founding for the entity named Weifang Hongtai New Material Technology Co., Ltd.

Key development milestones visible in the available sources include:

The creation of a medical-supplies-focused platform built around surgical packs, drapes, wound dressings, and disposable protective products.
Expansion into a broader multi-category supplier covering laboratory equipment, dental materials, rehabilitation products, and hospital furniture through a global supply-chain model.
Formalization of a wider chemical and new materials business, with references to research and development, production, sales, and technical services, as well as facilities in a chemical industry park.

Business Operations and Segments

The company’s operations are presented as part of a group structure with multiple business departments and product channels. Public descriptions indicate four broad activity areas: chemicals and plastic-related products, medical products, paper and packaging, and a Middle East market business line.

Main operating themes

Medical consumables and disposables: surgical gowns, drapes, packs, masks, gloves, shoe covers, isolation garments, and related items.
Wound care and treatment products: hydrocolloid dressings, IV film dressings, foam bandages, NPWT-related items, and other wound-management products.
Industrial and chemical materials: PVC, CPVC, PP, ACR, MBS, fine chemicals, pharmaceutical intermediates, plasticizers, and CPE resins are referenced in company descriptions and executive profiles.
Trading, export, and customization: the company emphasizes OEM/ODM support, customized orders, and international supply capabilities.

Products and Technologies

Hota’s product portfolio is centered on single-use medical and protective products with a secondary presence in chemical raw materials and plastics-related supply.

Medical and nonwoven products

The company describes six product categories that include:

Disposable medical and surgical non-woven products
Medical pads and wound dressings
Laboratory equipment
Dental materials
Treatment and rehabilitation products
Surgical-operation related supplies

Examples listed across source material include:

Surgical packs and drapes
Equipment drapes and covers
Isolation gowns and coveralls
Face masks, gloves, and shoe covers
Hydrocolloid wound dressings
NPWT films and foam bandages
Oxygen, anesthesia, and laryngeal masks
Catheter and urine-bag products

Technical characteristics

The available listings suggest a manufacturing and sourcing model oriented toward sterile or clean-room-compatible healthcare consumables, where product performance is tied to barrier protection, absorbency, breathability, adhesion, and infection-control requirements. Company and marketplace descriptions also point to EO sterilization for certain dressings, ISO-based quality systems, and regulatory readiness for CE and medical-device-related compliance in export markets.

A separate business line references plastics and chemical materials such as:

PVC resin
CPVC resin
PP resin
ACR resin
MBS resin
CPE
Plasticizers
Fine chemicals

This indicates that Hota is not limited to finished medical goods but also participates in upstream polymer and compound supply, which is relevant to pipes, fittings, and other plastics applications mentioned in executive profiles.

Applications and End Markets

Hota’s end markets are broader than healthcare procurement alone and include both institutional and industrial customers.

Hospitals and public procurement: the company explicitly describes itself as a one-stop supplier for hospital bidding projects and public-hospital supply chains.
Medical distributors and OEM buyers: product customization, branding, and contract manufacturing appear central to its business model.
Laboratories and clinics: laboratory items and wound-care products are listed among its offerings.
Construction, piping, and industrial users: the plastics and resin-related business lines imply downstream use in pipe, fittings, and general industrial materials.
International trade customers: the company states that it serves markets linked to China, Turkey, India, and Malaysia, with exports reaching multiple regions.

Global Presence and Market Position

Hota describes itself as a large supplier of disposable medical consumables and a globally connected supplier with production and distribution links extending across several countries. The company’s promotional materials cite supply-chain operations in China, Turkey, India, and Malaysia, and third-party supplier listings indicate exports to North and Latin America, Europe, the Middle East, and Southeast Asia.

Its market position appears to be that of a mid-sized, export-oriented specialty supplier rather than a vertically integrated multinational. Public listings emphasize responsiveness, customization, and a broad catalog more than scale-based dominance in any single product category.

Sustainability and Environmental Initiatives

The company’s chemical-facing website describes it as a high-tech chemical enterprise with a mission to provide sustainable, science-led solutions. It also presents itself as operating under quality and environmental management frameworks, including references to ISO 14001 certification in public profiles.

From the available sources, Hota’s sustainability profile is better characterized as compliance-oriented and process-focused than as a detailed environmental strategy. No source provided here quantifies emissions, recycled content, or decarbonization targets, so any stronger claim would be unsupported.

Financial Performance and Economic Impact

No audited financial statements, revenue figures, or formal annual reports were provided in the available sources, so the company’s financial performance cannot be reliably quantified here. Third-party supplier pages do suggest a workforce commonly described in the range of 201–300 employees on some platforms, while company materials also refer to 3 factories and substantial production capacity, but these figures should be treated as platform-reported claims rather than independently verified financial metrics.

Economically, Hota’s impact is most visible through:

Export activity in medical consumables and chemical materials.
Support for hospital procurement and OEM manufacturing.
Participation in plastics-linked supply chains, especially via resin and polymer product channels.

Leadership and Corporate Governance

Publicly available profiles identify Wu Guowei and Jolin Wu / Jolin Wu in leadership or general-manager roles across different platforms, while LinkedIn materials describe the company as a group organization with multiple departments. The company’s public information does not provide a detailed board structure or governance statement, so its governance profile remains limited to executive and contact-level disclosures.

Innovations and Future Outlook

Hota’s future positioning appears to depend on three linked capabilities:

Cross-category bundling of medical consumables, wound care, and related hospital supplies.
Customization and OEM/ODM execution, which is especially relevant in export and procurement-driven markets.
Parallel exposure to plastics and chemical materials, which may support broader industrial sales and sourcing flexibility.

In the wider plastics and healthcare materials ecosystem, the company’s prospects will likely be shaped by demand for single-use medical products, regulatory expectations for quality and traceability, and the cost and supply volatility of polymers, nonwovens, and chemical inputs.

References

•
CPS+ eMarketplace. (n.d.). WEIFANG HOTA NEW MATERIAL TECHNOLOGY CO., LTD.WEIFANG HOTA NEW MATERIAL TECHNOLOGY CO., LTD.. CPS+ eMarketplace. https://www.chinaplasonline.com/eMarketplace/ExhibitorInfo?CompId=1001802Link